New Era — Build to Buys | LSI USA '25

Industry leaders from Baxter International and top medtech innovators join moderator Joe Mullings to discuss the strategic shift toward "Build to Buy" models shaping the future of healthcare investments and acquisitions. For more information visit https://shorturl.at/Pes4n

Transatlantic Investing and Fund II Strategy, with Panakes Partners

Diana brings 23 years of venture capital experience and previously co-founded another successful venture capital firm called 360 Capital. Alessio, with an engineering background, co-founded Panakes in 2015 after working as a research engineer at Sofinnova Partners. Throughout the episode, Diana and Alessio provide valuable insights into the evolving landscape of medtech investing, shedding light on the complexities, challenges, and opportunities in the field. For more information visit here: https://shorturl.at/TNMk1

The Weekly Recap 4/25/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure $164M in new funding, receive regulatory clearances, achieve clinical milestones, and much more on the road to LSI Asia ‘25 in Singapore (June 10-13). This blog is originally published here: https://shorturl.at/9lARh

The Memo: NIMBLE Diagnostics Bringing Visibility to Vascular Implants

NIMBLE Diagnostics was born from a collaborative research effort among several investigators from the Germans Trias i Pujol Hospital and affiliated universities. From this joint initiative, cardiovascular researcher Dr. Oriol Iborra Egea and telecommunications engineer Susana Amorós took the lead and spearheaded the creation of the startup to make the technology a clinical reality. This blog is originally published here: https://shorturl.at/bjS1J

U.S. Medtech Market Growth: The Numbers Behind the Trends

The U.S. medtech market continues to be a dominant force globally, representing over 45% of the worldwide medtech revenue as of 2025. Despite recent concerns and headlines suggesting uncertainty, a deeper dive into the numbers tells a different story: one of resilience and steady expansion. Thanks to growing surgical procedure volumes and significant investments in innovation, the United States remains at the forefront of medtech development. In this article, we’ll explore the factors driving growth, key statistics, and the market’s long-term outlook for medtech companies. This blog is originally published here: https://shorturl.at/6wnc1